Evelyne Grisard

ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion

Julie A. Vendrell, Aurélie Thollet, Nhan Trung Nguyen et al. · Cancer Research · 2012 · 131 citations · Full text

Medicine, Cell Biology, Oncology +17

MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer

Paul Vilquin, Caterina F. Donini, Marie Villedieu et al. · Breast Cancer Research · 2015 · 79 citations · Full text

Medicine, Molecular Biology, Oncology +17

The critical role of the <scp>ZNF217</scp> oncogene in promoting breast cancer metastasis to the bone

Aurélie Bellanger, Caterina F. Donini, Julie A. Vendrell et al. · The Journal of Pathology · 2017 · 54 citations

Medicine, Cancer Biology, Oncology +12

ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells

Aurélie Thollet, Julie A. Vendrell, Léa Payen et al. · Molecular Cancer · 2010 · 51 citations · Full text

Medicine, Cancer Biology, Oncology +17

Molecular characterization of anastrozole resistance in breast cancer: Pivotal role of the Akt/mTOR pathway in the emergence of <i>de novo</i> or acquired resistance and importance of combining the allosteric Akt inhibitor MK‐2206 with an aromatase inhibitor

Paul Vilquin, Marie Villedieu, Evelyne Grisard et al. · International Journal of Cancer · 2013 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17